Abstract Submission

Click on the links below to go directly to any of the following sections:

 

Submit Your Abstract(s) 

Abstract submission is closed.
 

Acceptance Notification

The submitting author will be notified of acceptance by email the week of December 11, 2017.

Back to top

Abstract Submission Guidelines

Abstract Submission and Review Timeline
The deadline for abstract submission is Tuesday, November 7, 2017, midnight UTC. Peer review by the ISOPP Research Committee will take place between Wednesday, November 8 and Monday, December 11. The submitting author will be notified of acceptance by email the week of December 11, 2017.
 
Presenting Author Registration
The presenting author MUST register for ISOPP 2018 by Monday, January 29, 2018 or the abstract will automatically be withdrawn.
 
Publication of Abstracts
All accepted abstracts will be published in an issue of the Journal of Oncology Pharmacy Practice provided the presenting author registers for the Symposium by Monday, January 29, 2018. By submitting an abstract, you consent to the publication of this abstract.
 
Conflict of Interest Disclosure
During the abstract submission process, you will be asked to disclose any conflict of interest.
 
Author Information
The first author MUST be the presenting author.
 
Information required from all authors:
  • Name
  • Phone number
  • Email address
  • Affiliation
  • ISOPP member or non-member
 
Preferred Presentation Type
Please select one of the following presentation options during online abstract submission:
  1. Platform or Poster (only ISOPP members will be considered for platform (oral) presentations)
  2. Poster

Posters will be presented as electronic posters (e-posters), see Poster Presentation Information for details. Encore presentations are only accepted as posters.

 
Abstract Categories
  1. Process Improvement/Pharmacoeconomics (PR): includes drug preparation and delivery, projects to enhance patient care or improve effectiveness or efficiency of pharmacy services; cost-benefit analyses; cost-effectiveness analyses
  2. Clinical Science (CS): includes oncology/pharmacy practice; MUEs; innovative patient care services/activities; unusual/unique clinical and/or management cases; projects to document pharmacy interventions
  3. Translational/Basic Science (TS): pharmacokinetics, pharmacodynamics, pharmacogenomics
  4. Trainee (TR): Student/Resident Fellow/Pharmacy intern/pharmacist-in-training, etc.
  5. Encore Presentation (EN): For data/abstract that has previously been presented at another meeting or published in profession journal
 
Abstract Title
The abstract title must be less than 150 characters. If the title is longer than 150 characters, you will not be able to submit your abstract. Please use title case e.g. Upper and Lower Case and NOT UPPER CASE.
 
Abstract Length
The abstract length is limited to 250 words not including the abstract title, author names or affiliations.
 
Abstract Content
The submission system will prompt you to follow the following abstract format:
  1. Objective/Purpose
  2. Study Design/Methods
  3. Results/Key Findings
  4. Conclusion/Recommendations
Abstracts must describe completed research (abstracts that contain results and conclusions).
 
Language
Abstracts are accepted in English only.
 
Number of Submissions 
There is no limit to the number of abstract submissions.

Platform Presentation Information

The platform presentations will be scheduled during one plenary and one concurrent session. Each presentation is scheduled for 15 minutes including questions from the audience. Presentation specifics will be communicated to the submitting author closer to the Symposium date. The first author must be the presenting author, and will receive a certificate of presentation. 
 

Poster Presentation Information

Electronic Posters (e-posters)
You will not need to print and carry your poster(s) to Shanghai! Posters will be displayed as electronic posters (e-posters) instead of traditional paper posters.
 
If your abstract is accepted for poster presentation, you will be asked to submit an e-poster file to the ISOPP abstract management system, which is very simple:
 
You create your poster in Microsoft PowerPoint (5 slides). Once created, you upload your PowerPoint file using the abstract system’s existing password protected upload feature. Detailed directions will be provided in the poster acceptance notice.
 
The uploaded PowerPoint files will be converted into individual e-poster PDF files to preserve your content and formatting (including embedded video files). These individual PDFs will be combined into a single file and uploaded onto viewing stations.
 
E-Posters Display
E-posters will be on display on viewing stations, consisting of large screens on stands with laptops, and set up in the ISOPP 2018 Exhibit and Poster Hall for viewing on Wednesday, April 11 and Thursday, April 12. The combined e-posters PDF file will also be made available to attendees online, so posters can be viewed at their leisure during and after the Symposium.
 
Poster Viewing Session – Mandatory Presentation
A Poster Viewing Session will be held in the afternoon of Thursday, April 12. Poster presenters will be allotted a 5-minute timeslot to present their e-poster, followed by two minutes for questions. Presentation of your poster is mandatory. Once the presenting author registration deadline has passed, a presentation schedule will be shared with presenters and registrants.

Poster Award

Poster presentations will be judged by the ISOPP Research Committee and the best poster will be awarded with a certificate. Presenting authors have to be ISOPP members. Encore presentations are not eligible for the Poster Award.

 

Questions

If you have any questions regarding the abstract submission system contact the Abstract Manager at abstract@isopp.org.
 
If you have any questions regarding scientific content, contact Carole Chambers, ISOPP Research Committee Chair by email at research@isopp.org.
 

Sign up for ISOPP’s Community Newsletter to receive updates about abstract submission. If you are an ISOPP member, you are already signed up.

Back to top